Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today...
Vous n'êtes pas connecté
Maroc - MEDINDIA.NET - Health Watch - 11/01/2025 00:22
Highlights: AI accelerates drug discovery by identifying effective compounds for complex diseases like cancer Mu
Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today...
Artificial intelligence (AI) may soon play a valuable role in helping doctors identify which medlinksurvivors of childhood cancer/medlink need...
Australian researchers have uncovered a critical mechanism driving the growth and spread of glioblastoma – one of the most aggressive and lethal...
The Brain Builders Youth Development Initiative, BBYDI, has announced a nationwide essay competition for students in tertiary institutions across...
The Brain Builders Youth Development Initiative, BBYDI, has announced a nationwide essay competition for students in tertiary institutions across...
Oak Ridge National Laboratory's Center for Artificial Intelligence Security Research (CAISER) is shining a light on AI vulnerabilities. While AI...
DelveInsight’s, “PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) Pipeline Insight 2026” report provides comprehensive insights about...
BOAO, Hainan, March 27 (Xinhua) -- If the long queues snaking outside every AI-themed subforum and the buzz stirred up by robotic moderators and robot...
DelveInsight’s “C-MET Non-Small Cell Lung Cancer (C-MET+ NSCLC) Pipeline Insight 2026” report provides comprehensive insights about...
DelveInsight’s, “EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) Pipeline Insight 2026” report provides comprehensive insights about...